Skip to content
knowrare
HealthSignal
Your condition community

Living with ALG12-congenital disorder of glycosylation

An inherited condition starting in infancy with feeding trouble, slow growth, developmental delay, and low muscle tone.

Understanding ALG12-congenital disorder of glycosylation

ALG12-congenital disorder of glycosylation (ALG12-CDG) is an inherited disorder that can affect several body systems.

Signs usually start in infancy, including feeding problems and slow weight gain. Many people have intellectual disability, delayed development, and weak muscle tone, and some have seizures. Some have a small head and unusual facial features. Some males have a small penis or undescended testes. Many make low levels of antibodies. It is also known as congenital disorder of glycosylation type Ig.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Trouble feeding
  • Poor weight gain (failure to thrive)
  • Delayed speech and language
  • Delayed motor skills
  • Blood clotting problems
  • Ongoing runny nose (chronic rhinitis)

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include brain and nervous system specialists and genetic specialists.

  3. Consider genetic testing

    Changes in ALG12 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

  4. Connect with expert centers

    CDG CARE may keep lists of experts for this condition.

Care & treatment

Care team
Brain and nervous system specialists (neurologists); Genetic specialists (geneticists)
Expert care
Expert lists: CDG CARE
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with CDG CARE and other patient organizations
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Is genetic testing for ALG12 available for our family?
How should antibody levels and infections be monitored?
Which therapies can support feeding and development?

Quick facts

Symptoms usually startNewborn and as an Infant
InheritanceAutosomal Recessive
GenesALG12

Changes in the ALG12 gene cause this condition. A child inherits a changed copy of the gene from each parent (autosomal recessive).

GeneticNeurologicalInherited Metabolic

Also known as: alg12-cdg; carbohydrate deficient glycoprotein syndrome type ig; cdg ig; cdg syndrome type ig; cdg-ig; cdg1g

Patient organizations

Source: NIH GARD · ALG12-congenital disorder of glycosylationGARD ID 9833 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with ALG12-congenital disorder of glycosylation.

Explore the ALG12-congenital disorder of glycosylation blog

Explore research for ALG12-congenital disorder of glycosylation

Explore actively recruiting ALG12-congenital disorder of glycosylation studies with HealthSpark.

HealthSpark

Find actively recruiting studies for ALG12-congenital disorder of glycosylation with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting ALG12-congenital disorder of glycosylation studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for ALG12-congenital disorder of glycosylation

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor ALG12-congenital disorder of glycosylation

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your ALG12-congenital disorder of glycosylation experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.